The award was initially established following a donation from The Wellcome Foundation. Since 2002 it was supported by GlaxoSmithKline Limited. The first award was made in 1980 and the last award in 2016.
The Royal Society GlaxoSmithKline Prize and Lecture was awarded biennially for original contributions to medical and veterinary sciences published within ten years from the date of the award. There was no restriction on the nationality of the recipient.
The medal was made of gold and was accompanied by a gift of £2,500. The award was normally made to one individual and the winner was called upon to deliver a lecture at the Society.
Professor Andrew Hattersley FMedSci FRS was awarded the Royal Society
GlaxoSmithKline Prize and Lecture 2016 for his work on genetic and
physiological studies of patients with common subtypes of monogenic
diabetes revolutionising treatment for these patients.
Dr Nicholas Lydon FRS was awarded the Royal Society GlaxoSmithKline Prize and Lecture 2014
for the development of the drug imatinib, a targeted tyrosine kinase
inhibitor that has transformed the treatment of chronic myelogenous
leukaemia (CML) and is a paradigm for cancer drug discovery.
See full list of all past winners of the Royal Society GlaxoSmithKline Prize and Lecture.
This award is supported by GlaxoSmithKline Limited.